Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05624229 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy of Proton Pump Inhibitors in Cirrhotic Patients With Acute Variceal Bleeding

StatusNot Yet Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 28, 2023 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: Dec 1, 2022 to Oct 1, 2023v2 Show 4 more changesShow less
    • Study completion date: Dec 31, 2025 to Dec 31, 2028
    • Interventions: Proton Pump Inhibitors (Drug) to No Proton Pump Inhibitors (Drug), Proton Pump Inhibitors (Drug)
    • Secondary endpoints revised (4)
    • Study description shortened, about 15 words
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Acute Variceal Bleeding (AVB) in patients with liver cirrhosis is a common clinical critical disease. There is little evidence for the effect of proton pump inhibitor (PPI) use in patients with AVB, and there is no study on the efficacy of PPI combined with standard therapy in patients with AVB.
Trial Details
NCT Number NCT05624229
Lead Sponsor West China Hospital
Conditions
(from sponsor)		 Upper Gastrointestinal Hemorrhage
Related terms Gastrointestinal Hemorrhage, Liver Cirrhosis
Enrollment 672 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov